| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |